Mapfre

COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

PDF page sample
Pages
54
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
18/06/25
During its Asset Management deep dive, Legal & General reiterated the FY28 targets for the division, originally set at last June’s Capital Markets ...
06/06/25
With just days to go before Mediobanca’s AGM, the battle for influence is heating up. For Generali’s shareholders, we believe the key questions are: ...
04/06/25
We have raised our valuation on Uniqa, as we believe the company’s value is not fully captured by its IFRS 17 results alone. The key source of this ...
04/06/25
We have raised our forecasts for Uniqa following the release of its 1Q25 results. Despite a significant decline in the financial result – mainly due ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO